We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

Late filing of evidence in support of a CTM opposition

  • Bird & Bird
  • -
  • European Union, Germany, Portugal
  • -
  • February 21 2008

The German company K & L Ruppert Stiftung & Co. Handels-KG (“Ruppert”) lodged an opposition against the registration by three Portuguese individuals of the figurative mark CORPO LIVRE

Distribution of copyright works

  • Bird & Bird
  • -
  • European Union, Germany
  • -
  • May 29 2008

Cassina, an Italian furniture manufacturer, brought an infringement action against Peek & Cloppenburg (“P&C”), a German clothes retailer, for fitting out a customer rest area in one of its clothing shops with Le Corbusier chairs and displaying a chair in a shop window

Bundesgerichtshof on Community trade marks: no infringement through unauthorised use as company name

  • Bird & Bird
  • -
  • European Union, Germany
  • -
  • May 16 2008

In the “Céline” decision (judgment of 11 September 2007, Case C-1706), the European Court of Justice (ECJ) confirmed that third party use of a sign must occur as trade mark genuine use, i.e. use “in relation to goods andor services”, in order to fall under Art. 5 (1) of the Trade Mark Directive (Directive 89104EEC) or Art. 9 (1) of the Community Trade Mark Regulation (CTMR

New ECJ reference in relation to supplementary protection certificates for medicinal products

  • Bird & Bird
  • -
  • European Union, Germany, United Kingdom
  • -
  • December 20 2007

The latest reference to the ECJ under Council Regulation (EEC) No 179892 concerning the creation of a supplementary protection certificate for medicinal products, which establishes the scheme by which supplementary protection certificates (SPCs) enable de facto patent term extension of up to 5 years to be secured for pharmaceuticals, concerns the time limit for filing an application for such an SPC